ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 46 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $354 | -25.5% | 325 | 0.0% | 0.00% | – |
| Q4 2022 | $475 | -52.5% | 325 | +91.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 170 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 170 | +70.0% | 0.00% | – |
| Q1 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 100 | -39.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 164 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 164 | +64.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -66.7% | 100 | -75.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |